Treatment challenges in and outside a network setting: Soft tissue sarcomas
- Pasquali S.
- Bonvalot S.
- Tzanis D.
- Casali P. G.
- Trama A.
- Gronchi A.
- Hackl M.
- Van Eycken E.
- Henau K.
- Dimitrova N.
- Sekerija M.
- Dusek L.
- Magi M.
- Malila N.
- Leinonen M.
- Velten M.
- Troussard X.
- Bouvier V.
- Guizard A. -V.
- Bouvier A. -M.
- Arveux P.
- Maynadie M.
- Woronoff A. -S.
- Robaszkiewicz M.
- Baldi I.
- Monnereau A.
- Tretarre B.
- Colonna M.
- Molinie F.
- Bara S.
- Schvartz C.
- Lapotre-Ledoux B.
- Grosclaude P.
- Stabenow R.
- Luttmann S.
- Nennecke A.
- Engel J.
- Schubert-Fritschle G.
- Heidrich J.
- Bernd Holleczek
- Jonasson J. G.
- Clough-Gorr K.
- Comber H.
- Mazzoleni G.
- Giacomin A.
- Sardo A. S.
- Barchielli A.
- Serraino D.
- De Angelis R.
- Mallone S.
- Tavilla A.
- Pierannunzio D.
- Rossi S.
- Santaquilani M.
- Knijn A.
- Pannozzo F.
- Gennaro V.
- Benfatto L.
- Ricci P.
- Autelitano M.
- Spagnoli G.
- Fusco M.
- Usala M.
- Vitale F.
- Michiara M.
- Tumino R.
- Mangone L.
- Falcini F.
- Ferretti S.
- Filiberti R. A.
- Marani E.
- Iannelli A.
- Sensi F.
- Piffer S.
- Gentilini M.
- Madeddu A.
- Ziino A.
- Maspero S.
- Candela P.
- Stracci F.
- Tagliabue G.
- Rugge M.
- Gatta G.
- Botta L.
- Capocaccia R.
- Pildava S.
- Smailyte G.
- Calleja N.
- Johannesen T. B.
- Rachtan J.
- Gozdz S.
- Blaszczyk J.
- Kepska K.
- de Lacerda G. F.
- Bento M. J.
- Miranda A.
- Diba C. S.
- Almar E.
- Larranaga N.
- de Munain A. L.
- Torrella-Ramos A.
- Diaz Garcia J. M.
- Marcos-Gragera R.
- Sanchez M. J.
- Navarro C.
- Salmeron D.
- Moreno-Iribas C.
- Galceran J.
- Carulla M.
- Mousavi M.
- Bouchardy C.
- Ess S. M.
- Bordoni A.
- Konzelmann I.
- Rashbass J.
- Gavin A.
- Brewster D. H.
- Huws D. W.
- Visser O.
- Bielska-Lasota M.
- Primic-Zakelj M.
- Kunkler I.
- Benhamou E.
DOIAbstract
Patients with soft tissue sarcoma (STS) experienced better outcomes when treated according to existing clinical practice guidelines either at reference institution or dedicated treatment networks. Despite increasing evidence supporting referral to sarcoma specialised units, up to half of patients are not managed according to guidelines, particularly those in the early stage of their disease requiring surgery. Also, criteria to certify expertise of institutions, such as the treatment volume, are debated and health authorities have only recently started identification of these centres and creation of treatment networks in Europe as well as in several countries. This process have important implications for both patient outcomes and innovation ...
Add to ORKG